⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GTBP News
GT Biopharma Inc. Common Stock
Form 8-K
sec.gov
GTBP
After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
globenewswire.com
GTBP
FATE
NKTX
CMPX
CRBU
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
globenewswire.com
IOVA
GTBP
NKTX
IBRX
FATE
A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company
prnewswire.com
GTBP
IPHA
INKT
IPSC
GT Biopharma Provides Update on Pipeline Discovery Activities from Newly Implemented AI-Based Technological Initiatives
globenewswire.com
GTBP
The $13 Million Company Teaching the Immune System to Hunt Cancer
prnewswire.com
NKTX
GTBP
IBRX
FATE
ARTV
Form 8-K
sec.gov
GTBP
Three TriKE Candidates In Clinic As NK Cell Engager Field Reorganizes
prnewswire.com
NKTX
GTBP
IBRX
FATE
INMB
B7-H3 Becomes The Hottest Antigen In Oncology, And One NK Engager Enters Clinic
prnewswire.com
IPHA
GTBP
GSK
SMMT
IDYA
GT Biopharma Reports First Quarter 2026 Financial Results
globenewswire.com
GTBP